Зеркальная кафедра анестезиологии и реаниматологии профессора Зельмана В.Л. ИМПЗ

Medicine & Life Sciences

1. Acute Coronary Syndrome 31%
2. Acute Kidney Injury 22%
3. Adrenergic Agents 10%
4. Ambulatory Surgical Procedures 12%
5. Anesthesia 48%
6. Anesthesiologists 14%
7. Anesthetics 23%
8. Antihypertensive Agents 10%
9. Arterial Pressure 9%
10. Assisted Reproductive Techniques 12%
11. Bariatric Surgery 11%
12. Blood Coagulation Factors 17%
13. Blood Pressure 10%
14. Blood Volume 14%
15. Brain 10%
16. Calcium 21%
17. Calcium Chloride 11%
18. Carbon 10%
19. Carbon Fiber 14%
20. Catecholamines 9%
21. Clinical Laboratory Techniques 17%
22. Clinical Protocols 20%
23. Cohort Studies 10%
24. Conduction Anesthesia 8%
25. Confidence Intervals 18%
26. Coronary Artery Bypass 37%
27. Coronary Artery Disease 16%
28. Coronary Vessels 8%
29. Coronavirus 39%
30. Coronavirus Infections 14%
31. Critical Care 27%
32. Dacarbazine 13%
33. Dexamethasone 9%
34. Disinfectants 12%
35. Epidural Analgesia 12%
36. Feasibility Studies 10%
37. Geriatrics 9%
38. Guidelines 22%
39. Heart Arrest 10%
40. Hemodynamics 19%
41. Hemorrhage 21%
42. Hemorrhagic Shock 18%
43. Hemostasis 22%
44. Hemostatic Disorders 8%
45. Hemostatics 18%
46. Hospitalization 11%
47. Hypertension 19%
48. Hypotension 20%
49. Immunosuppressive Agents 8%
50. Infant Mortality 11%
51. Intensive Care Units 10%
52. Intravenous Anesthesia 40%
53. Intravenous Anesthetics 14%
54. Kidney Neoplasms 11%
55. Malnutrition 19%
56. Metals 8%
57. Mortality 31%
58. Multicenter Studies 10%
59. Myocardial Infarction 16%
60. Myocardial Revascularization 28%
61. Nutrition Assessment 8%
62. Observational Studies 8%
63. Obstetrics 21%
64. Oxygen 8%
65. Pandemics 34%
66. Pathology 9%
67. Perfusion 10%
68. Perioperative Period 23%
69. Placebos 20%
70. Placenta Accreta 14%
71. Pneumonia 13%
72. polyetheretherketone 15%
73. Polymers 9%
74. Postoperative Complications 11%
75. Postoperative Period 12%
76. Postpartum Hemorrhage 13%
77. Proprotein Convertase 9 15%
78. Prospective Studies 16%
79. Random Allocation 9%
80. Randomized Controlled Trials 35%
81. Sevoflurane 8%
82. Simendan 15%
83. Smoking 7%
84. Survival 12%
85. Therapeutics 13%
86. Thiamine 12%
87. Thoracic Surgery 100%
88. Thrombelastography 33%
89. Tranexamic Acid 46%
90. Transplants 11%
91. Transurethral Resection of Prostate 14%
92. Troponin 9%
93. Troponin I 12%
94. Urology 11%
95. Uterine Artery Embolization 14%
96. Venous Insufficiency 13%
97. Weaning 29%